ZERVIATE 0.24 % Ophthalmic Solution
RxNorm 2119481
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2119481 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ZERVIATE 0.24 % Ophthalmic Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Cetirizine 2.4 mg/ML Ophthalmic Solution [Zerviate]
(Atom ID: 12366269)
PSNPrescribable
Prescribable Name (PSN):
ZERVIATE 0.24 % Ophthalmic Solution
(Atom ID: 10827441)
SYPrescribable
Synonym (SY):
Zerviate 0.24 % Ophthalmic Solution
(Atom ID: 10827446)
SYPrescribable
Synonym (SY):
Zerviate 2.4 mg/ML Ophthalmic Solution
(Atom ID: 10827442)
Patient Education
Cetirizine Ophthalmic
Cetirizine ophthalmic is used to relieve the itching of allergic pink eye. Cetirizine is in a class of medications called antihistamines. It works by blocking the action of histamine, a substance in the body that causes allergic symptoms.
[Learn More]
* Please review the disclaimer below.